Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Foghorn Therapeutics Inc stock

Learn how to easily invest in Foghorn Therapeutics Inc stock.

Foghorn Therapeutics Inc is a biotechnology business based in the US. Foghorn Therapeutics Inc shares (FHTX) are listed on the NASDAQ and all prices are listed in US Dollars. Foghorn Therapeutics Inc employs 119 staff and has a trailing 12-month revenue of around $9.2 million.

How to buy shares in Foghorn Therapeutics Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FHTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Foghorn Therapeutics Inc stock price (NASDAQ: FHTX)

Use our graph to track the performance of FHTX stocks over time.

Foghorn Therapeutics Inc shares at a glance

Information last updated 2022-10-02.
Latest market close$8.25
52-week range$7.35 - $24.34
50-day moving average $12.31
200-day moving average $13.60
Wall St. target price$21.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.75

Buy Foghorn Therapeutics Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Foghorn Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Foghorn Therapeutics Inc price performance over time

Historical closes compared with the close of $8.25 from 2022-10-03

1 week (2022-09-28) -1.55%
1 month (2022-09-02) -17.58%
3 months (2022-07-05) -43.49%
6 months (2022-04-05) -49.01%
1 year (2021-10-05) -39.43%
2 years (2020-10-01) N/A
3 years (2019-10-01) N/A
5 years (2017-10-01) N/A

Foghorn Therapeutics Inc financials

Revenue TTM $9.2 million
Gross profit TTM $-79,006,000
Return on assets TTM -20.91%
Return on equity TTM -144.18%
Profit margin 0%
Book value $1.14
Market capitalisation $357.2 million

TTM: trailing 12 months

Foghorn Therapeutics Inc share dividends

We're not expecting Foghorn Therapeutics Inc to pay a dividend over the next 12 months.

Foghorn Therapeutics Inc overview

Foghorn Therapeutics Inc. , a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609, a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and with Loxo Oncology to create novel oncology medicines.

Frequently asked questions

What percentage of Foghorn Therapeutics Inc is owned by insiders or institutions?
Currently 26.21% of Foghorn Therapeutics Inc shares are held by insiders and 62.171% by institutions.
How many people work for Foghorn Therapeutics Inc?
Latest data suggests 119 work at Foghorn Therapeutics Inc.
When does the fiscal year end for Foghorn Therapeutics Inc?
Foghorn Therapeutics Inc's fiscal year ends in December.
Where is Foghorn Therapeutics Inc based?
Foghorn Therapeutics Inc's address is: 500 Technology Square, Cambridge, MA, United States, 02139
What is Foghorn Therapeutics Inc's ISIN number?
Foghorn Therapeutics Inc's international securities identification number is: US3441741077

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site